iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Mankind Pharma Ltd Option Chain

Add as a Preferred Source on Google
2,244.4
(1.38%)
Jan 14, 2026|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Ol (lots)Call PriceStrike PricePut PriceOl (lots)
--1,800₹1.85 0%5,6250%
2250%₹288.45 0%1,900₹0.5 0%9000%
--1,950₹4.5 0%1,3500%
--1,980₹1.5 -48.27%16,2000%
4,2750%₹318.6 0%2,000₹1.5 -50%18,6753.75%
--2,020--
--2,040₹4.05 50%1,8000%
--2,060₹3.05 -60.89%13,2753.50%
2250%₹135.5 0%2,080₹3.45 -50.71%29,025-1.52%
3,3750%₹139.95 -0.21%2,100₹4.35 -59.53%45,900-5.55%
--2,120₹11.85 0%2250%
6750%₹90.5 0%2,140₹7.4 -69.67%18,00053.84%
11,4750%₹98.7 0%2,150₹8.15 -64.25%33,525-5.09%
9000%₹91.3 26.98%2,160₹10 -61.31%22,05048.48%
6,525-19.44%₹82.35 57.75%2,180₹12.85 -56.44%10,57580.76%
96,075-46.28%₹61.35 19.59%2,200₹18.3 -48.3%1,16,3251.37%
24,975-21.27%₹47.15 12.93%2,220₹24.2 -52.54%18,2256.57%
38,25015.64%₹37.65 25.5%2,240₹33 -43.92%28,1255.04%
37,57530.46%₹33.3 19.78%2,250₹38.4 -36%19,8004.76%
73,8000.92%₹29.35 23.83%2,260₹46.45 -22.38%77,6253.91%
25,200-0.88%₹21.75 29.85%2,280₹70 0%3,6000%
2,20,950-10.15%₹16.3 15.6%2,300₹70.95 -18.54%38,025-5.58%
32,8500.68%₹12 7.14%2,320₹117 0%4,7250%
16,875-5.06%₹8.8 -18.13%2,340--
1,50,52521.85%₹7.6 10.14%2,350₹143.55 0%1,5750%
18,22544.64%₹6.4 7.56%2,360--
2,7000%₹15.25 0%2,380--
1,21,2755.47%₹3.85 6.94%2,400₹159.35 -17.94%5,8500%
2250%₹3.9 0%2,420--
--2,440₹225.5 0%2250%
1,02,60018.13%₹3.1 10.71%2,450₹210.75 -11.44%2,025-40%
6750%₹9.35 0%2,460--
47,70081.19%₹2.2 18.91%2,500₹279 0%5,1750%
4,0500%₹1.7 0%2,520--
12,825-3.38%₹0.25 -72.22%2,560--
4500%₹1 0%2,600₹400 0%1,3500%
225-50%₹0.25 0%2,700₹515 0%2250%

Mankind Pharma: Related NEWS

Mankind Pharma Q1 Updates: Net profit down ~18%

The company also informed that its diluted earnings per share (EPS) slipped by 20.10% on a yearly basis to ₹10.60.

1 Aug 2025|01:41 PM
Read More
Top Stocks for Today - 01st August 2025

Here are some of the stocks that may see significant price movement today: Coal India, Mankind Pharma, Swiggy, etc.

1 Aug 2025|08:58 AM
Read More
Mankind Pharma posts mixed performance in Q4; stock slips ~4%

The business said that it logged a 10.70% year-on-year decline in its consolidated net profit at ₹420.80 Crore for Q4FY25.

22 May 2025|12:15 PM
Read More
Top Stocks for Today - 22nd May 2025

Here are some of the stocks that may see significant price movement today: NBCC, IndusInd Bank, Hindustan Zinc, etc.

22 May 2025|06:38 AM
Read More
Mankind Pharma Faces ₹183.11 Crore Tax Demand

The cumulative demand, including interest charges, is ₹183.11 crore.

30 Mar 2025|04:34 PM
Read More
Mankind Pharma Merges Three Subsidiaries

The merger took effect on March 29, 2025, after all necessary regulatory approvals were obtained.

30 Mar 2025|01:33 PM
Read More
Mankind Pharma Faces ₹111.68 Crore Tax Demand, Plans to Appeal

The tax adjustments pertain to Section 80IC/80IE, which involves deductions for businesses in special economic zones, and a disallowance of certain expenditures under Section 37(1) of the Act.

28 Feb 2025|11:13 PM
Read More
Top Stocks for Today - 24th January 2025

Here are some of the stocks that may see significant price movement today: Indus Towers, Dr Reddy’s Laboratories, Mankind Pharma, etc.

24 Jan 2025|07:50 AM
Read More
Mankind Pharma Q3 Profit Falls 16%, Revenue Jumps 24%

The company reported a good growth in EBITDA of 36.8% to ₹830 crore in the quarter against ₹606.5 crore in Q3 FY24.

23 Jan 2025|11:57 PM
Read More
Mankind Pharma Secures ₹5,000 Crore NCDs by Pledging 56.31% Stake in BSV

The NCDs issued are categorized, rated, secured, redeemable, and transferable, distributed across three series.

8 Jan 2025|04:01 PM
Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.